BIIB|Biogen Inc.
Biogen Inc. is a global biotechnology company that discovers, develops, and delivers innovative therapies for serious neurological and neurodegenerative diseases. The company focuses on areas with significant unmet medical needs, including multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, amyotrophic lateral sclerosis, and other neurological and immunology conditions. Biogen's business model involves extensive research and development, strategic collaborations with other biopharmaceutical companies, and commercialization of its products through a global sales and marketing infrastructure. It serves patients, healthcare providers, and healthcare systems worldwide, aiming to transform patient care through advanced science and medicine.